Paper39903487
Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis.
Desouter AK and 16 others. Diabetes Care, 2025. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis. Papers, record 39903487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39903487
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Blood Glucose | Major topic |
| Blood Glucose Self-Monitoring | Major topic |
| Humans | |
| Glucose Tolerance Test | |
| Male | |
| Female | |
| Longitudinal Studies | |
| Adolescent | |
| Child | |
| Glycated Hemoglobin | |
| Adult | |
| Young Adult | |
| Disease Progression | |
| Continuous Glucose Monitoring |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Junior research fellowship 11D1214N | Fonds Wetenschappelijk Onderzoek | PubMed | ||
| IWT 130 138 | Departement Economie, Wetenschap en Innovatie | PubMed | ||
| Funding for the Belgian Diabetes Registry | Wetenschappelijk Fonds Willy Gepts, Universitair Ziekenhuis Brussel | PubMed | ||
| Funding for the Belgian Diabetes Registry | Center for Medical Innovation Flanders | PubMed | ||
| Free-of-charge materials. No other involvement. | Medtronic Europe | PubMed | ||
| Free-of-charge materials. No other involvement. | Bayer | PubMed |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23780460 | Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. | JAMA | 2013 | https://conductscience.org/library/papers/23780460 | PubMed |
| 2 | 15613948 | Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. | Epidemiology | 2005 | https://conductscience.org/library/papers/15613948 | PubMed |
| 3 | 17182981 | Relaxing the rule of ten events per variable in logistic and Cox regression. | Am J Epidemiol | 2007 | https://conductscience.org/library/papers/17182981 | PubMed |
| 4 | 32457058 | C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNet. | Diabetes Care | 2020 | https://conductscience.org/library/papers/32457058 | PubMed |
| 5 | 30556249 | Diabetic ketoacidosis at diagnosis of type 1 diabetes and glycemic control over time: The SEARCH for diabetes in youth study. | Pediatr Diabetes | 2019 | https://conductscience.org/library/papers/30556249 | PubMed |
| 6 | 33179853 | Adherence to oral glucose tolerance testing in children in stage 1 of type 1 diabetes: The TEDDY study. | Pediatr Diabetes | 2021 | https://conductscience.org/library/papers/33179853 | PubMed |
| 7 | 19469679 | Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. | Diabetes Technol Ther | 2009 | https://conductscience.org/library/papers/19469679 | PubMed |
| 8 | 36459177 | The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes. | Diabetologia | 2023 | https://conductscience.org/library/papers/36459177 | PubMed |
| 9 | 36326757 | Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening. | Diabetes Care | 2022 | https://conductscience.org/library/papers/36326757 | PubMed |
| 10 | 26404926 | Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. | Diabetes Care | 2015 | https://conductscience.org/library/papers/26404926 | PubMed |
| 11 | 31180194 | An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31180194 | PubMed |
| 12 | 34880069 | CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study. | Diabetes Care | 2022 | https://conductscience.org/library/papers/34880069 | PubMed |
| 13 | 25524912 | HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk. | Diabetes | 2015 | https://conductscience.org/library/papers/25524912 | PubMed |
| 14 | 36730530 | CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study. | Diabetes Care | 2023 | https://conductscience.org/library/papers/36730530 | PubMed |
| 15 | 39642898 | Dysglycaemia definitions and progression to clinical type 1 diabetes in children with multiple islet autoantibodies. | Lancet Diabetes Endocrinol | 2025 | https://conductscience.org/library/papers/39642898 | PubMed |
| 16 | 30089716 | β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis. | JCI Insight | 2018 | https://conductscience.org/library/papers/30089716 | PubMed |
| 17 | 39159241 | Early Dysglycemia Is Detectable Using Continuous Glucose Monitoring in Very Young Children at Risk of Type 1 Diabetes. | Diabetes Care | 2024 | https://conductscience.org/library/papers/39159241 | PubMed |
| 18 | 25985749 | OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis. | Diabetologia | 2015 | https://conductscience.org/library/papers/25985749 | PubMed |
| 19 | 26409458 | Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes. | Diabetologia | 2015 | https://conductscience.org/library/papers/26409458 | PubMed |
| 20 | 21972409 | Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. | Diabetes Care | 2011 | https://conductscience.org/library/papers/21972409 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42450641 | Glucose Dysregulation as a Driver of Autoimmune Mimicry, Inflammation, and Psychiatric Symptoms: A Narrative Review. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42450641 | PubMed |
| 42149241 | GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection. | Diabetologia | 2026 | https://conductscience.org/library/papers/42149241 | PubMed |
| 41913320 | Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/41913320 | PubMed |
| 41803288 | Continuous glucose monitoring as a tool in early-stage type 1 diabetes. | Diabetologia | 2026 | https://conductscience.org/library/papers/41803288 | PubMed |
| 41618706 | Impact of screening programmes for type 1 diabetes in youth: A systematic review and meta-analysis. | Diabet Med | 2026 | https://conductscience.org/library/papers/41618706 | PubMed |
| 41535597 | Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes. | Diabetologia | 2026 | https://conductscience.org/library/papers/41535597 | PubMed |
| 41317333 | Type 1 Diabetes and Other Autoimmune Diseases-Epidemiology, Pathophysiology and Screening. | Endocrinol Diabetes Metab | 2026 | https://conductscience.org/library/papers/41317333 | PubMed |
| 41211799 | Optimizing Type 1 Diabetes Screening in People With Family History: A German Perspective. | J Diabetes Sci Technol | 2025 | https://conductscience.org/library/papers/41211799 | PubMed |
| 41157252 | Continuous Glucose Monitoring in People at High Risk of Diabetes and Dysglycaemia: Transforming Early Risk Detection and Personalised Care. | Life (Basel) | 2025 | https://conductscience.org/library/papers/41157252 | PubMed |
| 41137714 | Are We Ready With Prevention for Type 1 Diabetes? | Diabetes Metab Res Rev | 2025 | https://conductscience.org/library/papers/41137714 | PubMed |
| 41035242 | Continuous glucose monitoring in Korean pediatric patients with type 1 diabetes: current landscape and clinical implications. | Clin Exp Pediatr | 2025 | https://conductscience.org/library/papers/41035242 | PubMed |
| 40928674 | Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council. | Diabetologia | 2025 | https://conductscience.org/library/papers/40928674 | PubMed |
| 40828811 | Longitudinal Continuous Glucose Monitoring Study in Young Children With Presymptomatic Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) At-Risk Cohort Study. | Diabetes Care | 2025 | https://conductscience.org/library/papers/40828811 | PubMed |
| 40553147 | Immune cell-adipose tissue crosstalk in metabolic diseases with a focus on type 1 diabetes. | Diabetologia | 2025 | https://conductscience.org/library/papers/40553147 | PubMed |
| 40134221 | Type 1 diabetes risk factors, risk prediction and presymptomatic detection: Evidence and guidance for screening. | Diabetes Obes Metab | 2025 | https://conductscience.org/library/papers/40134221 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39903487
GET https://conductscience.org/api/papers/v1/39903487/references?page=2